Cancer Immunotherapy at SITC 2019: The Good, the Bad and the Solution

The Society for Immunotherapy of Cancer's 34th Annual Meeting hosted an array of multidisciplinary and interactive sessions focused on basic and applied cancer immunotherapy. The introduction of Immune Checkpoint Inhibitors (ICIs) has caused a revolution in cancer therapy; these treatments...

and / December 16, 2019

SITC 2019 may be over, but the era of Spatial Genomics enabled by the GeoMx Digital Spatial Profiler has just begun.

The curtains have fallen on SITC 2019—the 34th annual meeting organized by the Society for Immunotherapy of Cancer—but excitement amongst the participants remains high after five days of knowledge exchange and networking with the brightest stars in the field of...

and / December 10, 2019

Immunotherapy in Tumors: Integrated Information to Outsmart Cancer

If it wasn’t such a devastating disease, there would be memes about how super-smart cancer is. Cancer cells can express neoantigens — tumor-specific, mutated peptides — that, when processed and presented by the MHC to T cells, mount an adequate...

/ December 2, 2019

Spatial Profiling using the GeoMx RNA Assay for NGS Readout: Robust Technology for Identification of Novel Biomarkers and Early Detection of Melanoma

Early diagnosis of melanoma is critical for improved clinical outcomes and survival of patients. Yet disagreement in traditional histology-based diagnosis frequently occurs.  Despite currently available molecular technologies, melanomas characterized by low cellularity and heterogeneity can hinder accurate diagnosis. To address...

/ November 19, 2019

A Transcriptomic Solution Customized for Your Every Need

The flexibility of the NanoString® nCounter® platform has been designed to accommodate a wide range of organisms, molecular targets, and sample inputs. Researchers can request “made-to-order” Custom CodeSets for up to 800 project-specific mRNA targets. In doing so, they can...

/ November 11, 2019